Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 Feb;99(2):269–275. doi: 10.1111/j.1365-2249.1995.tb05544.x

The effect of free and liposome-encapsulated clodronate on the hepatic mononuclear phagocyte system in the rat.

J P Camilleri 1, A S Williams 1, N Amos 1, A G Douglas-Jones 1, W G Love 1, B D Williams 1
PMCID: PMC1534290  PMID: 7851021

Abstract

Clodronate, encapsulated within small unilamellar vesicles (SUVc) will deplete hepatic macrophages after intravenous injection. Functional studies, using probes to evaluate hepatic Fc and C3b uptake, showed a close correlation between the inhibition of receptor-mediated uptake and the depletion of hepatic macrophages. Twenty milligrams of clodronate encapsulated within SUVc produced > or = 90% inhibition of uptake and clearance of Fc- and C3b-coated erythrocytes and a comparable reduction of hepatic macrophage numbers. Inhibition of macrophage receptor-mediated uptake of these erythrocytes was closely related to the reduction in macrophage numbers. Repopulation of macrophages within the liver took place over 2 weeks. At 1 week after depletion, although repopulation was taking place, receptor-mediated function remained suppressed. In a preliminary experiment, treatment of rats with adjuvant arthritis with 20 mg clodronate encapsulated in SUV suppressed the inflammation and reversed the course of the disease, while treatment with 20 mg free clodronate in saline or 20 mg clodronate in multilamellar vesicles (MLVc) did not.

Full text

PDF
269

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bogers W. M., Stad R. K., Janssen D. J., van Rooijen N., van Es L. A., Daha M. R. Kupffer cell depletion in vivo results in preferential elimination of IgG aggregates and immune complexes via specific Fc receptors on rat liver endothelial cells. Clin Exp Immunol. 1991 Nov;86(2):328–333. doi: 10.1111/j.1365-2249.1991.tb05818.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Burmester G. R., Jahn B., Rohwer P., Zacher J., Winchester R. J., Kalden J. R. Differential expression of Ia antigens by rheumatoid synovial lining cells. J Clin Invest. 1987 Sep;80(3):595–604. doi: 10.1172/JCI113111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chu C. Q., Field M., Feldmann M., Maini R. N. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 1991 Sep;34(9):1125–1132. doi: 10.1002/art.1780340908. [DOI] [PubMed] [Google Scholar]
  4. Diamond A. G., Larkins A. P., Wright B., Ellis S. T., Butcher G. W., Howard J. C. The alloantigenic organization of RT1Aa, a class I major histocompatibility complex molecule of the rat. Eur J Immunol. 1984 May;14(5):405–412. doi: 10.1002/eji.1830140505. [DOI] [PubMed] [Google Scholar]
  5. Dijkstra C. D., Döpp E. A., Joling P., Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology. 1985 Mar;54(3):589–599. [PMC free article] [PubMed] [Google Scholar]
  6. Dunn C. J., Galinet L. A., Wu H., Nugent R. A., Schlachter S. T., Staite N. D., Aspar D. G., Elliott G. A., Essani N. A., Rohloff N. A. Demonstration of novel anti-arthritic and anti-inflammatory effects of diphosphonates. J Pharmacol Exp Ther. 1993 Sep;266(3):1691–1698. [PubMed] [Google Scholar]
  7. Firestein G. S., Alvaro-Gracia J. M., Maki R., Alvaro-Garcia J. M. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol. 1990 May 1;144(9):3347–3353. [PubMed] [Google Scholar]
  8. Firestein G. S., Zvaifler N. J. How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum. 1990 Jun;33(6):768–773. doi: 10.1002/art.1780330602. [DOI] [PubMed] [Google Scholar]
  9. Flora L. Comparative antiinflammatory and bone protective effects of two diphosphonates in adjuvant arthritis. Arthritis Rheum. 1979 Apr;22(4):340–346. doi: 10.1002/art.1780220405. [DOI] [PubMed] [Google Scholar]
  10. Howard J. C., Butcher G. W., Galfrè G., Milstein C., Milstein C. P. Monoclonal antibodies as tools to analyze the serological and genetic complexities of major transplantation antigens. Immunol Rev. 1979;47:139–174. doi: 10.1111/j.1600-065x.1979.tb00292.x. [DOI] [PubMed] [Google Scholar]
  11. Love W. G., Amos N., Kellaway I. W., Williams B. D. Specific accumulation of cholesterol-rich liposomes in the inflammatory tissue of rats with adjuvant arthritis. Ann Rheum Dis. 1990 Aug;49(8):611–614. doi: 10.1136/ard.49.8.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Love W. G., Camilleri J. P., Williams B. D. Efficient clodronate entrapment within multilamellar and unilamellar liposomes. J Pharmacol Toxicol Methods. 1992 May;27(3):185–189. doi: 10.1016/1056-8719(92)90039-4. [DOI] [PubMed] [Google Scholar]
  13. Saklatvala J. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature. 1986 Aug 7;322(6079):547–549. doi: 10.1038/322547a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Steven M. M., Lennie S. E., Sturrock R. D., Gemmell C. G. Enhanced bacterial phagocytosis by peripheral blood monocytes in rheumatoid arthritis. Ann Rheum Dis. 1984 Jun;43(3):435–439. doi: 10.1136/ard.43.3.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Van Rooijen N., Kors N., vd Ende M., Dijkstra C. D. Depletion and repopulation of macrophages in spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate. Cell Tissue Res. 1990 May;260(2):215–222. doi: 10.1007/BF00318625. [DOI] [PubMed] [Google Scholar]
  16. Williams B. D., O'Sullivan M. M., Saggu G. S., Williams K. E., Williams L. A., Morgan J. R. Synovial accumulation of technetium labelled liposomes in rheumatoid arthritis. Ann Rheum Dis. 1987 Apr;46(4):314–318. doi: 10.1136/ard.46.4.314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Yousaf N., Howard J. C., Williams B. D. Demonstration of hepatic Fc receptor function in vivo. Clin Exp Immunol. 1989 Nov;78(2):278–284. [PMC free article] [PubMed] [Google Scholar]
  18. Yousaf N., Howard J. C., Williams B. D. Studies in the rat of antibody-coated and N-ethylmaleimide-treated erythrocyte clearance by the spleen. I. Effects of in vivo complement activation. Immunology. 1986 Sep;59(1):75–79. [PMC free article] [PubMed] [Google Scholar]
  19. Yousaf N., Howard J. C., Williams B. D. Studies in the rat of antibody-sensitized and N-ethylmaleimide-treated erythrocyte clearance by the liver: effects of immune complex infusion and complement activation. Immunology. 1988 Jun;64(2):193–199. [PMC free article] [PubMed] [Google Scholar]
  20. van Lent P. L., van den Bersselaar L., van den Hoek A. E., van de Ende M., Dijkstra C. D., van Rooijen N., van de Putte L. B., van den Berg W. B. Reversible depletion of synovial lining cells after intra-articular treatment with liposome-encapsulated dichloromethylene diphosphonate. Rheumatol Int. 1993;13(1):21–30. doi: 10.1007/BF00290330. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES